Evolution of multi‐drug resistant hepatitis B virus during sequential therapy
Hyung Joon Yim, Munira Hussain, Ying Liu, Stephen N. Wong, Scott K. Fung, Anna S. F. Lok – 29 August 2006 – Multi‐drug resistant hepatitis B virus (HBV) has been reported in hepatitis B patients who received sequential antiviral therapy. In vitro studies showed that HBV constructs with mutations resistant to lamivudine and adefovir have marked reduction in sensitivity to combination of lamivudine and adefovir, whereas constructs with mutations resistant to either drug remain sensitive to the other drug.